Showing results (1161-1170 of 1,649) with videos related to

Sort By:
Pageof 165
Clinical and Translational Medicine|February 19, 2024
LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6 A modification in triple-negative breast cancerYuanhang Yu, Huifang Deng, Wenwen Wang, et al.
Clinical and Translational Medicine|February 19, 2024
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic indexYongjie Wang, Xiaolong Ma, Enjie Xu, et al.
Clinical and Translational Medicine|February 16, 2024
Tolerating CD47Jeffrey S Isenberg, Enrique Montero
Clinical and Translational Medicine|February 16, 2024
Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasisYuqi Jiao, Yongjun Yu, Minying Zheng, et al.
Clinical and Translational Medicine|November 20, 2023
The potential clinical impact of cell type-specific genetic regulation: Crohn's diseaseRika Tyebally, Angli Xue, Joseph E Powell
Clinical and Translational Medicine|November 20, 2023
Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectivesChentao Zou, Xinquan Zan, Zhenyu Jia, et al.
Clinical and Translational Medicine|November 20, 2023
H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodellingBonan Chen, Xiaoli Liu, Peiyao Yu, et al.
Clinical and Translational Medicine|November 20, 2023
The m5 C methyltransferase NSUN2 promotes codon-dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancerPeng Li, Wenlong Wang, Ruixin Zhou, et al.
Clinical and Translational Medicine|November 14, 2023
Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathwayChunxiao Ma, Min Liu, Wenxin Feng, et al.
Clinical and Translational Medicine|October 20, 2023
Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short-term intensive insulin therapy for type 2 diabetesZhe Xu, Junyu He, Peng Han, et al.
Pageof 165